Follow us on Twitter

Tuesday, 12 June 2012

VaxInnate Begins Phase I Clinical Trial to Evaluate H5N1 Vaccine Candidate for ... - MarketWatch (press release)



VaxInnate Begins Phase I Clinical Trial to Evaluate H5N1 Vaccine Candidate for ... - MarketWatch (press release)
INFLUENZA - GOOGLE NEWS | 12 JUNE 2012
http://pulse.me/s/addaa
VaxInnate Begins Phase I Clinical Trial to Evaluate H5N1 Vaccine Candidate for ...MarketWatch (press release)VAX161 is a ... Read more


Posted by Rob LW
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)